Wayne Winegarden
Business & Economics
Drug Prices That Matter
Too often, drug pricing analyses do not shed light on how much drug expenditures are actually increasing because these studies examine the wrong price. The latest iteration is an analysis by Rx Savings Solutions. According to the Wall Street Journal, Rx Savings Solutions documented that dozens of drug makers raised the ...
Wayne Winegarden
January 3, 2019
California
California’s energy mandates amount to state-legislated energy poverty
Every Californian wants to conserve energy and see cleaner air and water in the Golden State. But in their quest to safeguard the state’s environment for future generations, Sacramento policymakers have put in place an overzealous regulatory scheme that negatively impacts poor and minority communities. The new Pacific Research Institute ...
Wayne Winegarden
December 21, 2018
Commentary
A Cost-Saving Medical Revolution If We Can Finance It
Despite the constant barrage of negative news, this is an exciting time for patients. Truly innovative medicines and gene therapies are under development. New gene therapies are particularly exciting because these therapies do not just treat diseases – they often cure them by fixing underlying genetic defects, frequently with only ...
Wayne Winegarden
December 17, 2018
Commentary
New York mandates create ‘energy poverty’ for citizens
New York has a proud tradition of environmental conservation. From Frederick Law Olmsted creating Central Park in the 1870s to the national environmental movement inspired by trailblazing President Theodore Roosevelt to the lush nature preserves created in the Adirondack and Catskills mountains, wise environmental stewardship has always been a cornerstone ...
Wayne Winegarden
December 15, 2018
Business & Economics
Protecting The Medicines Of Tomorrow
Government solutions often come with a price. For the America Invents Act (AIA), this price was an unintended impediment to medical innovation. Proposed legislation known as the Hatch-Waxman Integrity Act can reduce these costs, if Congress takes advantage of the opportunity. The problem of patent trolls plaguing Silicon Valley was ...
Wayne Winegarden
December 12, 2018
Blog
Proxy Advisory Firms Are Worsening CalPERS and CalSTRS ESG Problem
My last blog post discussed the risks that ESG investing creates for CalPERS and CalSTRS. If not addressed, then both taxpayers and public employees will bear unnecessary costs and risks. Unfortunately, SEC rules are making this problem even worse. The SEC requires all institutional investors, such as CalPERS and CalSTRS, ...
Wayne Winegarden
December 11, 2018
Business & Economics
New Study Shows California/New York Approach to Fighting Global Warming Hurts Working Class and Minority Communities
Legislating Energy Poverty Shows Market-Based Policies More Effective in Cutting Emissions The big government approach to fighting ‘global warming’ taken by California and New York hits working class and minority communities the hardest, a new report released today by the California-based free-market think tank, the Pacific Research Institute, concludes. “Overzealous ...
Wayne Winegarden
December 5, 2018
Blog
The ESG Threat to California’s Pensions
California’s public pensions are in trouble. While the Pew Charitable Trusts reports that California’s current unfunded liabilities are nearly $170 billion, as I recently reported in my chartbook on California’s pension crisis, the crisis is much worse. Valuing the liabilities using a more realistic market rate, the total pension debt ...
Wayne Winegarden
December 5, 2018
Business & Economics
Redefining Presidential Failure As Success
While success still has many fathers, failure is no longer an orphan. President Obama’s recent speeches and rallies demonstrate that, now, failure is simply redefined as success. The costs from this revisionism is high. Creating false narratives encourage policies that will harm economic prosperity and impose large economic hardships on ...
Wayne Winegarden
November 30, 2018
Business & Economics
The Bizarre World of Drug Pricing
There is no shortage of bad ideas when it comes to the pharmaceutical market. One such proposal would allow drugs to be imported directly from other countries, such as Canada. Then there is the Trump Administration’s proposal that would effectively adopt foreign price controls on Medicare Part B drugs by ...
Wayne Winegarden
November 19, 2018
Drug Prices That Matter
Too often, drug pricing analyses do not shed light on how much drug expenditures are actually increasing because these studies examine the wrong price. The latest iteration is an analysis by Rx Savings Solutions. According to the Wall Street Journal, Rx Savings Solutions documented that dozens of drug makers raised the ...
California’s energy mandates amount to state-legislated energy poverty
Every Californian wants to conserve energy and see cleaner air and water in the Golden State. But in their quest to safeguard the state’s environment for future generations, Sacramento policymakers have put in place an overzealous regulatory scheme that negatively impacts poor and minority communities. The new Pacific Research Institute ...
A Cost-Saving Medical Revolution If We Can Finance It
Despite the constant barrage of negative news, this is an exciting time for patients. Truly innovative medicines and gene therapies are under development. New gene therapies are particularly exciting because these therapies do not just treat diseases – they often cure them by fixing underlying genetic defects, frequently with only ...
New York mandates create ‘energy poverty’ for citizens
New York has a proud tradition of environmental conservation. From Frederick Law Olmsted creating Central Park in the 1870s to the national environmental movement inspired by trailblazing President Theodore Roosevelt to the lush nature preserves created in the Adirondack and Catskills mountains, wise environmental stewardship has always been a cornerstone ...
Protecting The Medicines Of Tomorrow
Government solutions often come with a price. For the America Invents Act (AIA), this price was an unintended impediment to medical innovation. Proposed legislation known as the Hatch-Waxman Integrity Act can reduce these costs, if Congress takes advantage of the opportunity. The problem of patent trolls plaguing Silicon Valley was ...
Proxy Advisory Firms Are Worsening CalPERS and CalSTRS ESG Problem
My last blog post discussed the risks that ESG investing creates for CalPERS and CalSTRS. If not addressed, then both taxpayers and public employees will bear unnecessary costs and risks. Unfortunately, SEC rules are making this problem even worse. The SEC requires all institutional investors, such as CalPERS and CalSTRS, ...
New Study Shows California/New York Approach to Fighting Global Warming Hurts Working Class and Minority Communities
Legislating Energy Poverty Shows Market-Based Policies More Effective in Cutting Emissions The big government approach to fighting ‘global warming’ taken by California and New York hits working class and minority communities the hardest, a new report released today by the California-based free-market think tank, the Pacific Research Institute, concludes. “Overzealous ...
The ESG Threat to California’s Pensions
California’s public pensions are in trouble. While the Pew Charitable Trusts reports that California’s current unfunded liabilities are nearly $170 billion, as I recently reported in my chartbook on California’s pension crisis, the crisis is much worse. Valuing the liabilities using a more realistic market rate, the total pension debt ...
Redefining Presidential Failure As Success
While success still has many fathers, failure is no longer an orphan. President Obama’s recent speeches and rallies demonstrate that, now, failure is simply redefined as success. The costs from this revisionism is high. Creating false narratives encourage policies that will harm economic prosperity and impose large economic hardships on ...
The Bizarre World of Drug Pricing
There is no shortage of bad ideas when it comes to the pharmaceutical market. One such proposal would allow drugs to be imported directly from other countries, such as Canada. Then there is the Trump Administration’s proposal that would effectively adopt foreign price controls on Medicare Part B drugs by ...